Zealand Pharma A/S
Smedeland 36
2600 Glostrup (Copenhagen)
Denmark
VIA EDGAR
April 11, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: |
| Sonia Bednarowski | |
|
|
| |
Re: |
| Zealand Pharma A/S | |
|
| Registration Statement on Form F-3 | |
|
| File No. 333-230654 | |
|
|
| |
|
| Acceleration Request | |
|
| Requested Date: | Monday April 15, 2019 |
|
| Requested Time: | 4:00 P.M. Eastern Daylight Time |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 (File No. 333-230654) (the “Registration Statement”) to become effective on April 15, 2019, at 4:00 p.m. Eastern Daylight Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).
The Registrant hereby authorizes each of Marc Recht, Josh Kaufman and Layne Jacobs of Cooley LLP to make such request on its behalf.
If you have any questions regarding this request, please contact Marc Recht of Cooley LLP at (617) 937-2316 or Josh Kaufman of Cooley LLP at (212) 479-6495. Thank you for your assistance with this matter.
[Signature Page Follows]
Sincerely, |
|
| |||
|
|
|
| ||
ZEALAND PHARMA A/S |
|
| |||
|
|
|
| ||
|
|
|
| ||
By: | /s/ Ravinder Chahil |
|
| ||
| Ravinder Chahil |
|
| ||
| Vice President, General Counsel |
|
| ||
|
|
|
| ||
|
|
|
| ||
cc: |
| Marc Recht, Cooley LLP |
|
| |
|
| Josh Kaufman, Cooley LLP |
|
| |
|
| Layne Jacobs, Cooley LLP |
|
| |